APA

Grabenbauer G. G., Rödel C., Brunner T., Schulze-Mosgau S., Strnad V., Müller R. G., Iro H. & Sauer R. (20010830). Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997. : Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Chicago

Grabenbauer G G, Rödel C, Brunner T, Schulze-Mosgau S, Strnad V, Müller R G, Iro H and Sauer R. 20010830. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997. : Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Harvard

Grabenbauer G. G., Rödel C., Brunner T., Schulze-Mosgau S., Strnad V., Müller R. G., Iro H. and Sauer R. (20010830). Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997. : Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

MLA

Grabenbauer G G, Rödel C, Brunner T, Schulze-Mosgau S, Strnad V, Müller R G, Iro H and Sauer R. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997. : Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 20010830.